Search

Now showing items 1-1 of 1

Benefit Of High-Dose Methylprednisolone In Comparison With Conventional-Dose Prednisolone During Remission Induction Therapy In Childhood Acute Lymphoblastic Leukemia For Long-Term Follow-Up

Yetgin, S; Tuncer, MA; Cetin, M; Gumruk, F; Yenicesu, I; Tunc, B; Oner, AF; Toksoy, H; Koc, A; Aslan, D; Ozyorek, E; Olcay, L; Atahan, L; Tuncbilek, ET; Gurgey, A (Nature Publishing Group, 2003)

Eight-year event-free survival (EFS) was evaluated in 205 patients with acute lymphoblastic leukemia (ALL), to consider the efficacy of high-dose methylprednisolone (HDMP) given during remission induction chemotherapy ...